Business - Healthcare
Endo To Buy Indevus
The deal is likely a harbinger of more consolidation among small drug makers.
Categories: Forbes
Endo Shifts Gears With Indevus
The first biopharma acquisition of the year as the industry consolidates.
Categories: Forbes
ConMed Struck Down By Dollar Gain
The medical device maker lowers its Q4 2008 guidance.
Categories: Forbes
Health Spending Continues To Explode
New government figures show generic drugs slowed zooming outlays, but not by much.
Categories: Forbes
The Strangest Sleep Disorders
From sexual sleepwalking to dying of nightmares, science struggles with these sleeping riddles.
Categories: Forbes
The Worst Places To Be Sick And Poor
The quality of state Medicaid programs varies widely, according to two studies.
Categories: Forbes
St. Jude Goes With The Cash Flow
Recession-resistant medical devices maker grabs two smaller companies as it expands globally.
Categories: Forbes
ArthroCare Shares Burned By Accounting
Medical-device maker extends its slide as investors stampede for the exits.
Categories: Forbes
ArthroCare Shares Dissolve
The medical-device company has to restate financials due to irrresponsible accounting.
Categories: Forbes
Tamiflu's Troubles
The government said Roche's flu treatment is failing to cure certain strains this season.
Categories: Forbes
The Deadliest Cold-Weather States
More people die from the cold in these locales than any other. Alaska makes the list. Washington, D.C., does too.
Categories: Forbes
Pfizer Becomes Auxilium's European Envoy
The pharmaceutical giant acquires European rights to Xiaflex.
Categories: Forbes
Auxilium Seals Deal With Pfizer
The biotech sells European rights to the pharmaceutical company.
Categories: Forbes
Pain-Free Cadence
The biotech reports positive results from a late-stage drug study.
Categories: Forbes
Cancer Doctors Fear Chemo Drug Shortage
The inability of two drug makers to produce a generic cancer medicine endangers both patients and research.
Categories: Forbes
Beckman Builds On Sales
Medical-device maker able to raise prices, sees strong 2009.
Categories: Forbes
In A First, Pfizer Doesn't Raise Dividend
The decision, though expected, is emblematic of the drug industry's woes.
Categories: Forbes
Melnyk Lifts His Biovail Stake
Founder adds to holdings in company he has been unable to influence.
Categories: Forbes
FDA Verdict Could Determine Future Of Personalized Medicine
An advisory panel is set to debate what standards need to be applied before gene tests are approved with cancer drugs.
Categories: Forbes
David Whelan On Health Insurance
Look for President Barack Obama to use some of his political capital to start chipping away at the problem of the uninsured.
Categories: Forbes
Bookmark this site
Bookmark this page
Make Us your homepage

